Shares of AbbVie Inc. (NYSE:ABBV) opened at 61.65 on Thursday. The growth estimate for the next quarter is 9.5 percent. (NYSE:ABBV) by 6.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The growth estimate for the next five years is 14.38 percent (per annum).
EPS growth for this year is 16.20% and EPS growth for next year is expected to reach at 17.20%. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs approximately 30,000 people worldwide and markets medicines in more than 170 countries. For ABBV, the company now has $- of cash on the books, which is offset by $- current liabilities. 15 analysts projected on average Earnings. Vanguard Group Inc. increased its position in shares of AbbVie by 1.0% in the second quarter. On average, equities research analysts expect that AbbVie will post $4.82 earnings per share for the current year. The High end of the Estimate is $6.56 Billion, while the Low end of the Estimate is $6.38 Billion.
If it is supposed that a firm preserves some part of its profits after dividend disbursement in a specified year, it can be argued that in order to preserve the capital framework, a suitable amount of debt can be recorded.
Price Target plays a critical role when it comes to the Analysis of a Stock. AbbVie now has a consensus rating of "Hold" and a consensus price target of $70.17. AbbVie has an average rating of "Hold" and an average target price of $70.17. At recent session, the prices were hovering between $60.81 and $61.91. The firm has a market cap of $99.91 billion, a P/E ratio of 16.94 and a beta of 1.57. The dividend stock is -8% off a 52-week high stock price of US$68.12 but is up 21.05% since hitting the US$53.74. The stock is 0.28% above another chart threshold, its 50-day moving average and 1.06% above its 20-day simple moving average. First PREMIER Bank raised its position in AbbVie by 1,850.0% in the third quarter. AbbVie had a return on equity of 150.77% and a net margin of 24.08%. The company's Relative strength index is 56.79. Analysts giving shares a rating of 1 or 2 would be indicating a Buy. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell. The Low Price target projection by analysts is $49 and the Mean Price Target is $69.78.
Analyst recommendation for this stock stands at 2.50.
Ltd. (NASDAQ:WIX) jumped 178.24 percent over the past one year, while it rose 18.86 percent year to date (YTD). For trailing twelve months, EPS value for the stock is $6.18.
In related news, CFO William J. Chase sold 6,600 shares of the stock in a transaction that occurred on Friday, December 2nd. The stock is now trading 25.33 percent higher from its SMA-50. Recently shares have been suggested as BUY from 9 and 0 issued SELL signal for the company's stock.11 told as a HOLD the stock.
Shares of Home Depot Inc (NYSE:HD) declined -0.46% to $141.54. The firm had revenue of $6.78 billion for the quarter, compared to the consensus estimate of $6.92 billion.